Ambid Pharmaceuticals Private Limited
About Ambid Pharmaceuticals Private Limited
Data last updated:
Ambid Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 16 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24239BR2019PTC040614. Its GSTIN is 10AARCA8053H1ZP (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors including Sonali Shekhar and Arun Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sri.Dinesh Sharma Lt Ram Chandra Sharma Rcb/116 B.H.Colony Bahadurpur, Patna, Bihar, India – 800026.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.13 Lakh, a decline of 68% compared to the previous year. For the same year it recorded a net loss of ₹5.47 Lakh (net margin -89.2%) and EBITDA of -₹97,579 (EBITDA margin -15.9%). Revenue has declined at a compounded annual rate (CAGR) of 52% over three years.
Company details
Contact details
Ambid Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressSri.Dinesh Sharma Lt Ram Chandra Sharma Rcb/116 B.H.Colony Bahadurpur, Patna, Bihar, India – 800026
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Ambid Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ambid Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ambid Pharmaceuticals Private Limited, buy the company report.
Financials of Ambid Pharmaceuticals Private Limited
FY 2025 filings availableAmbid Pharmaceuticals Private Limited reported revenue of ₹6.13 Lakh (down 68% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 52% over three years, including a 68% fall in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹97,579 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.47 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -15.9% | ||||
| Net Profit Margin | -89.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ambid Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ambid Pharmaceuticals Private Limited
Ambid Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sonali Shekhar Also directs: Kushmanda Health Care LLP, Kushmanda Ventures LLP, Rudransh Engicon Private Limited and 1 more | Director | 16 Jan 2019 | 7 Years 9 Months | Current |
| Arun Kumar Also directs: Kushmanda Health Care LLP, Kushmanda Ventures LLP, Mahabodhi Developers Private Limited and 2 more | Director | 16 Jan 2019 | 7 Years 9 Months | Current |
| Ajay Kumar Also directs: Kushmanda Health Care LLP, Kushmanda Ventures LLP, Mahabodhi Developers Private Limited and 1 more | Director | 16 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Ambid Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mediseth Medicare Pharmaceuticals Private Limited | ₹6.13 Lakh (FY 2024) | 85.0% | Gurugram, Haryana, India | |||
| Ambid Pharmaceuticals Private Limitedthis company | ₹6.13 Lakh (FY 2025) | -₹5.47 Lakh | -89.2% | -68.0% | Patna, Bihar, India | |
| Lords Pharmaceuticals Private Limited | ₹6.12 Lakh (FY 2022) | Bhubaneshwar, Odisha, India | ||||
| Navi Pharmaceuticals Private Limited | ₹6.11 Lakh (FY 2020) | -61.0% | New Delhi, Delhi, India | |||
| Wyenne Davis Pharmaceuticals Private Limited | ₹6.1 Lakh (FY 2025) | 34.0% | Palakkad, Kerala, India |
To see the full peer comparison of Ambid Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ambid Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ambid Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ambid Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AARCA8053H1ZP | Bihar | Active | 04 Apr 2019 |
To see the full GST registrations and return filing status of Ambid Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ambid Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Ajay Kumar was appointed as Director on 16 Jan 2019.
Frequently asked questions
Ambid Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 16 January 2019 (7+ years old) and is registered under CIN U24239BR2019PTC040614.
Ambid Pharmaceuticals has 3 current directors:
- Sonali Shekhar - Director
- Arun Kumar - Director
- Ajay Kumar - Director
The latest financial statements of Ambid Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Ambid Pharmaceuticals is 10AARCA8053H1ZP, registered in Bihar.
The CIN (Corporate Identification Number) of Ambid Pharmaceuticals is U24239BR2019PTC040614. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ambid Pharmaceuticals was incorporated on 16 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Ambid Pharmaceuticals by revenue are Mediseth Medicare Pharmaceuticals Private Limited, Lords Pharmaceuticals Private Limited, Navi Pharmaceuticals Private Limited, Wyenne Davis Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ajay Kumar was appointed as Director on 16 Jan 2019. Arun Kumar was appointed as Director on 16 Jan 2019. Sonali Shekhar was appointed as Director on 16 Jan 2019.
The registered office of Ambid Pharmaceuticals is at Sri.Dinesh Sharma Lt Ram Chandra Sharma Rcb116 B.H.Colony Bahadurpur, Patna, Bihar, India – 800026.
Ambid Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Ambid Pharmaceuticals can be reached at its registered office: Sri.Dinesh Sharma Lt Ram Chandra Sharma Rcb116 B.H.Colony Bahadurpur, Patna, Bihar, India – 800026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
